Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: Molecular evidence of incomplete resection

Oral Oncology

Volumn 37, Issue 6, 2001, Pages 505-512

  Zhang, L ^a   Poh, C F ^a   Lam, W L ^b   Epstein, J B ^a,b,c,d   Cheng, X ^a,e   Zhang, X ^e   Priddy, R ^a   Lovas, J ^f   Le, N D ^b   Rosin, M P ^b,e,g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SIMON FRASER UNIVERSITY   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Leukoplakia; Loss of heterozygosity; Molecular markers; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME; DISEASE SEVERITY; DYSPLASIA; EVALUATION; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HUMAN; LASER SURGERY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOUTH LESION; MOUTH TUMOR; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; HUMANS; LASER SURGERY; LEUKOPLAKIA, ORAL; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0034955455     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00140-8     Document Type: Article

References (29)

1. Oral precancer: Preventive and medical approaches to management
2. Oral leukoplakia: To treat or not?
3. Malignant transformation of leukoplakia
4. Malignant transformation of leukoplakia
5. Predicting cancer development in oral leukoplakia: Ten years of translational research
6. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma
7. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients
8. From epithelial dysplasia to squamous carcinoma in the head and neck region: An epidemiological assessment
9. Oral precancer: Patterns, complexities and clinical guidelines
10. Risk of preneoplastic and neoplastic events in operated oral leukoplakias
11. Genetic progression model for head and neck cancer: Implications for field cancerization
12. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization
13. Molecular analysis of oral lichen planus: A premalignant lesion?
14. High frequency of allelic loss in dysplastic lichenoid lesions
15. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
16. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
17. Can molecular assessment improve classification of head and neck premalignancy?
18. Definition of leukoplakia and related lesions: An aid to studies on oral precancer
19. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas
20. Anatomic origins and locations of oral cancer
21. A proposal for a classification and staging system for oral leukoplakia: A preliminary study
22. Phenotypic and genotypic disparity in premalignant lesions: Of calm water and crocodiles
23. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer
24. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids
25. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment
26. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy
27. 13-Cis-retinoic acid in the treatment of oral leukoplakia
28. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
29. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa